Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jul 10;6(7):912-26.
doi: 10.4239/wjd.v6.i7.912.

Mechanisms of hypoglycemia unawareness and implications in diabetic patients

Iciar Martín-Timón  1 , Francisco Javier Del Cañizo-Gómez  1
Affiliations
Review

Mechanisms of hypoglycemia unawareness and implications in diabetic patients

Iciar Martín-Timón et al. World J Diabetes. .

Abstract

Hypoglycemia unawareness (HU) is defined at the onset of neuroglycopenia before the appearance of autonomic warning symptoms. It is a major limitation to achieving tight diabetes and reduced quality of life. HU occurs in approximately 40% of people with type 1 diabetes mellitus (T1DM) and with less frequency in T2DM. Though the aetiology of HU is multifactorial, possible mechanisms include chronic exposure to low blood glucose, antecedent hypoglycaemia, recurrent severe hypoglycaemia and the failure of counter-regulatory hormones. Clinically it manifests as the inability to recognise impeding hypoglycaemia by symptoms, but the mechanisms and mediators remain largely unknown. Prevention and management of HU is complex, and can only be achieved by a multifactorial intervention of clinical care and structured patient education by the diabetes team. Less know regarding the impact of medications on the development or recognition of this condition in patients with diabetes. Several medications are thought to worsen or promote HU, whereas others may have an attenuating effect on the problem. This article reviews recent advances in how the brain senses and responds to hypoglycaemia, novel mechanisms by which people with insulin-treated diabetes develop HU and impaired counter-regulatory responses. The consequences that HU has on the person with diabetes and their family are also described. Finally, it examines the evidence for prevention and treatment of HU, and summarizes the effects of medications that may influence it.

Keywords: Counter-regulation; Diabetes mellitus; Hypoglycemia associated autonomic failure; Hypoglycemia unawareness; Impaired awareness of hypoglycemia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Counter-regulatory response to hypoglycemia.
Figure 2
Figure 2
Symptoms and signs associated with progressive hypoglycemia. ACTH: Adrenocorticotropic hormone; GH: Growth hormone.
Figure 3
Figure 3
Recurrent hypoglycemia leads to cellular adaptation and hypoglycemia-associated autonomic failure. HAAF: Hypoglycemia-associated autonomic failure.
See this image and copyright information in PMC

References

    1. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care. 2010;33:1389–1394. - PMC - PubMed
    1. de Galan BE, Schouwenberg BJ, Tack CJ, Smits P. Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes. Neth J Med. 2006;64:269–279. - PubMed
    1. Moghissi E, Ismail-Beigi F, Devine RC. Hypoglycemia: minimizing its impact in type 2 diabetes. Endocr Pract. 2013;19:526–535. - PubMed
    1. Briscoe VJ, Davis SN. Hypoglycemia in type 1 and type 2 diabetes: physiology, pathophysiology, and management. Clinical Diabetes. 2006;24:115–121.
    1. Vignesh JP, Mohan V. Hypoglycaemia unawareness. J Assoc Physicians India. 2004;52:727–732. - PubMed